News from the FDA/CDC

Baby boomers are the hepatitis C generation


 

Increases in hepatitis C–related inpatient stays for baby boomers from 2005 to 2014 far outpaced those of older adults, while younger adults saw their admissions drop over that period, according to the Agency for Healthcare Research and Quality.

For the baby boomers (adults aged 52-72 years), the rate of inpatient stays involving hepatitis C with or without hepatitis B, HIV, or alcoholic liver disease rose from 300.7 per 100,000 population in 2005 to 503.1 per 100,000 in 2014 – an increase of over 67%. For patients aged 73 years and older, that rate went from 104.4 in 2005 to 117.1 in 2014, which translates to a 12% increase, and for patients aged 18-51 years, it dropped 15%, from 182.5 to 155.4, the AHRQ said in a statistical brief.

Inpatient stays involving hepatitis C by age group
The increased admissions over that 10-year period were largely driven by hepatitis C, as the stays involving hepatitis B, HIV, or alcoholic liver disease and hepatitis C rose only 11% for all adults, compared with 49% for those with hepatitis C only, based on data from the National Inpatient Sample.

Along with the increased hospitalizations, “acute hepatitis C cases nearly tripled from 2010 through 2015,” the report noted, which was “likely the result of increasing injection drug use due to the growing opioid epidemic.”

Recommended Reading

Eradicating HCV significantly improved liver stiffness in meta-analysis
MDedge Family Medicine
Influenza: All that and MI too
MDedge Family Medicine
Zika-linked birth defects climbing in U.S. hot spots
MDedge Family Medicine
Antibiotic choice for acute otitis media 2018
MDedge Family Medicine
CDC: Flu levels highest since pandemic year 2009
MDedge Family Medicine
Birth cohort affected 2015-2016 flu vaccine effectiveness
MDedge Family Medicine
Trial seeks improved regimens for pregnant women with HIV
MDedge Family Medicine
Adacel Tdap effective throughout third trimester vaccination window
MDedge Family Medicine
Inpatient antibiotic resistance: Everyone’s problem
MDedge Family Medicine
FDA issues safety alert for loperamide
MDedge Family Medicine